AIMS: Our aim was to describe the changes in therapy and diabetes control in Ukrainian war refugee children with diabetes (CwD) during the first year of their stay in Czechia. METHODS: A total of 124 CwD (62 male, 62 female) were enrolled into this observational study. Anthropometric, laboratory and diabetes management data were acquired at baseline and at 3 months intervals for 12 months. All CwD were offered a CGM device during their first visit. Generalized Estimating Equation models were fitted in order to estimate the dynamics of studied characteristics. RESULTS: Median baseline HbA1c was 58 mmol/mol (IQR [48; 73]mmol/mol) (7.5 %, IQR[6.5;8.8]%). The HbA1c decreased significantly throughout the course of the study at a pace of - 2.2 mmol/mol (-0.2 %pt.) per visit (P = 0.01, CI[-3.2;-1.1]). The pace of the decrease in the average HbA1c was significantly higher in the group of CwD who received CGM in Czechia than in those who already had it from Ukraine by 2.9 mmol/mol (0.27 %pt.) per visit (P < 0.001, CI [-4.4; -1.3]). CONCLUSIONS: The steepest decrease in HbA1c was observed in CwD with newly initiated CGM underlining its vital role in improving the glucose control of CwD regardless of their background.
- Klíčová slova
- Children, Continuous glucose monitoring, Diabetes management, HbA1c, Type 1 diabetes, War refugees,
- MeSH
- diabetes mellitus 1. typu * farmakoterapie MeSH
- dítě MeSH
- glykovaný hemoglobin MeSH
- kontinuální monitorování glukózy MeSH
- krevní glukóza MeSH
- lidé MeSH
- selfmonitoring glykemie MeSH
- uprchlíci * MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- pozorovací studie MeSH
- Názvy látek
- glykovaný hemoglobin MeSH
- krevní glukóza MeSH
We performed the genetic analysis of Rasopathy syndromes in patients from Central European by direct sequencing followed by next generation sequencing of genes associated with Rasopathies. All 51 patients harboured the typical features of Rasopathy syndromes. Thirty-five mutations were identified in the examined patients (22 in PTPN11, two in SOS1, one in RIT1, one in SHOC2, two in HRAS, three in BRAF, two in MAP2K1 and two in the NF1 gene). Two of them (p.Gly392Glu in the BRAF gene and p.Gln164Lys in the MAP2K1 gene) were novel with a potentially pathogenic effect on the structure of these proteins. Statistically significant differences in the presence of pulmonary stenosis (63.64% vs. 23.81%, P = 0.013897) and cryptorchidism (76.47% vs. 30%, P = 0.040224) were identified as the result of comparison of the prevalence of phenotypic features in patients with the phenotype of Noonan syndrome and mutation in the PTPN11 gene, with the prevalence of the same features in patients without PTPN11 mutation. Cryptorchidism as a statistically significant feature in our patients with PTPN11 mutation was not reported as significant in other European countries (Germany, Italy and Greece). The majority of mutations were clustered in exons 3 (45.45%), 8 (22.73%), and 13 (22.73%) of the PTPN11 gene.
- Klíčová slova
- BRAF, MAP2K1, PTPN11, Rasopathies, cardio-facio-cutaneous syndrome, central Europe, noonan syndrome,
- MeSH
- běloši genetika MeSH
- dítě MeSH
- dospělí MeSH
- ektodermální dysplazie genetika MeSH
- exony MeSH
- faciální stigmatizace MeSH
- fenotyp MeSH
- intracelulární signální peptidy a proteiny genetika MeSH
- kojenec MeSH
- kryptorchismus genetika MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mutační analýza DNA * MeSH
- neprospívání genetika MeSH
- Noonanové syndrom genetika MeSH
- předškolní dítě MeSH
- protein SOS1 genetika MeSH
- Ras proteiny genetika MeSH
- stenóza pulmonální chlopně genetika MeSH
- tyrosinfosfatasa nereceptorového typu 11 genetika MeSH
- vrozené srdeční vady genetika MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- intracelulární signální peptidy a proteiny MeSH
- protein SOS1 MeSH
- PTPN11 protein, human MeSH Prohlížeč
- Ras proteiny MeSH
- RIT1 protein, human MeSH Prohlížeč
- SHOC2 protein, human MeSH Prohlížeč
- tyrosinfosfatasa nereceptorového typu 11 MeSH